Explore

Streams

Products

About Index

Index

By TNW

Samsara BioCapital

3216

Samsara BioCapital

Also headquartered in Palo Alto

Companies in the same industry

Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 13

Portfolio

Portfolio Tracker

Add info

$71,500,000 Venture capital (Series B)

A2 Biotherapeutics Closes $71.5M Series B Funding

$100,000,000 Undisclosed

Flame Biosciences Completes $100M Common Stock Financing

$239,000,000 Venture capital (Series D)

Recursion Raises $239M in Series D Equity Financing

Recursion Pharmaceuticals Raises $239 Million And Partners With Bayer For AI Drug Discovery

$106,000,000 Post-IPO equity

Chinook Therapeutics Raises $106M in Funding

Chinook Therapeutics raises $106M as it prepares to merge with Aduro Biotech

$93,500,000 Venture capital (Series C)

,

Bolt Biotherapeutics Raises $93.5M in Series C Financing

$76,000,000 Venture capital (Series B)

Autobahn Therapeutics Raises $76 Million To Develop Therapies For CNS Disorders

Autobahn Therapeutics Raises $76M in Series B Financing

Chinook Therapeutics to merge with Aduro Biotech as it pushes forward with kidney disease therapies

Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech

$45,000,000 Venture capital (Series C)

Palvella Therapeutics Closes $45M Series C Financing Round

$170,000,000 Venture capital (Series B)

ElevateBio Raises $170M in Series B Financing

Cell and gene therapy startup ElevateBio raises $170 million

$100,000,000 Venture capital (Series D)

Forma Therapeutics Closes $100M Series D Financing

$113,800,000 IPO

Biopharma firm Atreca goes public

$150,000,000 Venture capital (Series A)

ElevateBio racks up $150 mln Series A

$10,000,000 Venture capital

Palvella Therapeutics Receives $10M in Funding

VC-backed Sutro Biopharma debuts IPO

$125,000,000 Venture capital (Series C)

, ,

Atreca Raises $125M in Series C Funding

Funding